National Cancer Institute Breast Cancer Steering Committee Working Group Report on Meaningful and Appropriate End Points for Clinical Trials in Metastatic Breast Cancer

To provide evidence-based consensus recommendations on choice of end points for clinical trials in metastatic breast cancer, with a focus on biologic subtype and line of therapy. The National Cancer Institute Breast Cancer Steering Committee convened a working group of breast medical oncologists, pa...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Journal of clinical oncology 2018-11, Vol.36 (32), p.3259-3268
Hauptverfasser:	Seidman, Andrew D, Bordeleau, Louise, Fehrenbacher, Louis, Barlow, William E, Perlmutter, Jane, Rubinstein, Lawrence, Wedam, Suparna B, Hershman, Dawn L, Hayes, Jennifer Fallas, Butler, Lynn Pearson, Smith, Mary Lou, Regan, Meredith M, Beaver, Julia A, Amiri-Kordestani, Laleh, Rastogi, Priya, Zujewski, Jo Anne, Korde, Larissa A
Format:	Artikel
Sprache:	eng
Schlagworte:	Special
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!